ICDcodes.org
FY2027

E74.829Other disorders of citrate metabolism

BillableCC

Is E74.829 billable?

Yes — E74.829 is billable for FY2027. E74.829 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. E74.829 may be submitted for encounters from October 1, 2026 through September 30, 2027.

E74.829 at a glance

CodeE74.829
DescriptionOther disorders of citrate metabolism
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027

Which MS-DRGs does E74.829 group to?

E74.829 sits in MDC 10 and helps define the logic of 1 MS-DRG (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 642Inborn and Other Disorders of Metabolismmedical

As a secondary diagnosis, E74.829 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.

How is E74.829 listed in the Alphabetic Index?

These are the routes through the Alphabetic Index that lead to E74.829. They show the wording a clinician may have documented, which often differs from the Tabular description.

  • Disordercitrate metabolism NEC (of)
  • Disordermetabolism NOScitrate NEC (of)

Excludes1 — never code together — inherited from Chapter 4

The conditions below can never be reported together with E74.829 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Excludes1 — never code together — inherited from E70-E88

The conditions below can never be reported together with E74.829 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • androgen insensitivity syndrome (E34.5-)
  • congenital adrenal hyperplasia (E25.0)
  • hemolytic anemias attributable to enzyme disorders (D55.-)
  • Marfan syndrome (Q87.4-)
  • 5-alpha-reductase deficiency (E29.1)

Excludes1 — never code together — inherited from E74

The conditions below can never be reported together with E74.829 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • diabetes mellitus (E08-E13)
  • hypoglycemia NOS (E16.2)
  • increased secretion of glucagon (E16.3)
  • mucopolysaccharidosis (E76.0-E76.3)

Excludes2 — not included here — inherited from E70-E88

The conditions below are not part of E74.829, but a patient may have both at the same time. When documentation supports it, E74.829 and the excluded code may both be reported.

  • Ehlers-Danlos syndromes (Q79.6-)

How long has E74.829 existed?

E74.829 first appears in FY2025.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.

What other codes are in the E74.82 family? (1)